Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Molecular DevicesMolecular Devices
VS
Syneos HealthSyneos Health
Molecular Devices

Molecular Devices

3860 North First St, San Jose, CA, 95134, US

Last Update: 23/02/2026

View Profile
Between 750 and 799
https://www.moleculardevices.com
756/1000Fair

Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis,...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:745
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Syneos Health

Syneos Health

1030 Sync Street, Morrisville, 27560, US

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.syneoshealth.com
794/1000Fair

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a ta...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:23,166
Subsidiaries:17
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Molecular Devices

Molecular Devices

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Syneos Health

Syneos Health

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Molecular Devices in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Syneos Health in 2026.

Incidents

Incident History - Molecular Devices (X = Date, Y = Severity)

Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Syneos Health (X = Date, Y = Severity)

Syneos Health cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Molecular Devices

Molecular Devices

Incidents
No explicit notable incidents reported.
Syneos Health

Syneos Health

Incidents
No explicit notable incidents reported.

FAQ

Between Molecular Devices company and Syneos Health company, which one has the best AI Cybersecurity Score ?
Between Molecular Devices company and Syneos Health company, which one has experienced more cyber incidents in the past ?
Between Molecular Devices company and Syneos Health company, which one has experienced more cyber incidents this year ?
Between Molecular Devices company and Syneos Health company, which one has experienced at least one ransomware attack ?
Between Molecular Devices company and Syneos Health company, which one has experienced at least one data breach ?
Between Molecular Devices company and Syneos Health company, which one has experienced at least one targeted cyberattack ?
Between Molecular Devices company and Syneos Health company, which one has experienced at least one vulnerability ?
Between Molecular Devices company and Syneos Health company, which one holds the most compliance certifications ?
Between Molecular Devices company and Syneos Health company, which one holds the fewest compliance certifications ?
Between Molecular Devices company and Syneos Health company, which one has the most subsidiaries ?
Between Molecular Devices company and Syneos Health company, which one has the largest number of employees ?
Between Molecular Devices and Syneos Health, which company holds both SOC 2 Type 1 certifications ?
Between Molecular Devices and Syneos Health, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Molecular Devices or Syneos Health ?
Which company is PCI DSS compliant - Molecular Devices or Syneos Health ?
Between Molecular Devices and Syneos Health, which company complies with HIPAA regulations for healthcare data ?
Between Molecular Devices and Syneos Health, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
REFERENCES